Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEland Oil & Gas Regulatory News (ELA)

  • There is currently no data for ELA

Operations and Financing Update

24 Nov 2014 07:00

RNS Number : 7700X
Eland Oil & Gas PLC
24 November 2014
 



 

24 November 2014

 

Eland Oil & Gas PLC

("Eland" or the "Company")

 

 

Operations and Financing Update

 

Eland Oil & Gas plc (AIM: ELA), an oil & gas production, development and exploration company operating in West Africa with a principal focus on Nigeria, is pleased to announce the following operations and financing update.

 

Highlights

 

·

Opuama Field current average gross production over 3,500 bopd (1,575 bopd net to Elcrest Exploration and Production Nigeria Ltd ("Elcrest"), Eland's joint venture company) based on production days.

 

·

Average uptime on Opuama Field has increased month on month since August. Current average uptime in November 2014 of circa 90%. Current average uptime for Q4 2014 of over 74%.

 

·

Current OML 40 fourth quarter gross production in excess of 140,000 barrels of oil (63,000 barrels net to Elcrest).

 

·

First Oil condition precedent for drawdown of $22 million loan facility with Standard Chartered Bank complete. Availability of debt to be announced in the near term. The Company remains in advanced discussions to target a $75 million reserve based lending facility.

 

·

Current cash balance of $14.7 million as at 21 November 2014.

 

·

Elcrest's next oil lifting is expected to take place in December and is due to be a cargo of circa. 30,000 bbls of crude.

 

·

Dredging operations, which commenced in Q3 2014, continue at the Opuama Field and are nearing completion. Drilling operations planning ongoing for an extended OML 40 development programme in 2015.

 

 

George Maxwell, CEO of Eland Oil & Gas commented:

 

"Achieving a consistent level of production at Opuama has been the main objective of the management so we are very pleased with the positive developments the Company is making.

 

This consistency of production is now delivering the value from OML 40 while also allowing access to debt funding. This is hugely beneficial to our shareholders as it allows the Company to fully develop our assets without requiring any further equity funding.

 

Furthermore, the combination of a lower cost environment and our 5 year petroleum profits tax holiday on OML 40 means our netback per barrel remains significant even in the current economic environment of falling oil prices."

 

 

For further information:

Eland Oil & Gas PLC

+44 (0) 207 016 3180

George Maxwell, CEO

Louis Castro, CFO

Edward Cozens, IR

Canaccord Genuity Limited

+44 (0) 207 523 8000

Henry Fitzgerald-O'Connor

Peter Stewart

FirstEnergy Capital LLP

+44 (0) 207 448 0200

Majid Shafiq

Khalid Ahmed

Citigate Dewe Rogerson

+44 (0) 207 638 9571

Martin Jackson

Shabnam Bashir

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBJBMTMBATTBI
Date   Source Headline
15th Nov 20062:50 pmRNSAnnual Report
25th Oct 20062:18 pmRNSBlocklisting Interim Review
25th Oct 20067:30 amBUSElan Reports Third Quarter 2006 Financial Results
24th Oct 20061:00 pmBUSTYSABRI(R) Maintained Remission in Patients with Moderate-to-Severe Crohn's Disease Treated for Longer Than Two Years According to Data Presented This Week
18th Oct 20068:42 amRNSHolding in Company
10th Oct 20067:00 amBUSNotice of Results
6th Oct 20062:07 pmBUSNew Pharmacoeconomic Data on TYSABRI(R) Demonstrate Significant Reduction in Steroid Use and Hospitalizations in Patients with Multiple Sclerosis
4th Oct 20061:00 pmBUSHealth Canada Grants Approval of TYSABRI(TM) (natalizumab) for the Treatment of Multiple Sclerosis Following Priority Review
29th Sep 20062:00 pmBUSNew Data Presented at ECTRIMS Congress Show TYSABRI(R) Has Sustained Effect on Relapse Rate in Multiple Sclerosis Patients Treated for up to Three Years
11th Sep 200611:57 amRNSFinancial Statements
9th Aug 20068:58 amRNSHolding in Company
2nd Aug 20065:26 pmRNSDirector/PDMR Shareholding
2nd Aug 200612:12 pmRNSHolding in Company
29th Jun 200612:32 pmRNSHolding in Company
21st Jun 200610:01 amRNSHolding in Company
15th Jun 20068:20 amRNSHolding in Company
7th Jun 20068:02 amRNSFurther re Appointment
1st Jun 200611:58 amRNSHolding in Company
25th May 20063:31 pmRNSHolding in Companies
25th May 200612:37 pmRNSHolding in Company
19th May 20065:51 pmRNSDirectors/PDMR Shareholding
19th May 200610:56 amRNSHolding in Company
17th May 200612:16 pmRNSHolding in Company
12th May 20061:45 pmRNSDirector/PDMR Shareholding
24th Apr 200611:36 amRNSHolding in Company
20th Apr 20064:44 pmRNSDocument Availability
19th Apr 20063:30 pmRNSHolding in Company
13th Apr 200612:51 pmRNSHolding in Company
13th Apr 200612:04 pmRNSAnnual Information Update
10th Apr 200612:42 pmRNSBrochure of Particulars
3rd Apr 20063:39 pmRNSBrochure of Particulars
13th Mar 200611:47 amRNSHoldings in Company
10th Mar 20063:24 pmRNSDirector/PDMR Shareholding
9th Mar 20067:30 amRNSRestoration of Listing
9th Mar 20067:01 amRNSOL Notice - Restoration
7th Mar 20061:00 pmRNSSuspension - Elan Corp Plc
7th Mar 20061:00 pmRNSOL Notice - Suspension
15th Feb 200610:15 amRNSBrochure of Particulars
10th Feb 20064:55 pmRNSDirector/PDMR Shareholding
9th Feb 20065:32 pmRNSDirector/PDMR Shareholding
9th Feb 20063:54 pmRNSHolding in Company
8th Feb 200610:56 amRNSDirector/PDMR Shareholding
3rd Feb 20069:58 amRNSDirector/PDMR Shareholding
25th Jan 200611:19 amRNSHolding in Company
9th Dec 20054:02 pmRNSDirector/PDMR Shareholding
17th Nov 20052:31 pmRNSRE:Director/PDMR Shareholding
1st Nov 20055:32 pmRNSDirector/PDMR Shareholding
22nd Sep 20059:43 amRNSRe: Brochure of Particulars
23rd Aug 20055:12 pmRNSDirector/PDMR Shareholding
21st Jun 200511:32 amRNSBrochure of Particulars

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.